Trusting numbers: Uncertainty and the pathology laboratory

Medical Journal of Australia

Volumn 177, Issue 3, 2002, Pages 153-155

  White, Graham H ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; DIGOXIN; HEMOGLOBIN A1C; HEPATITIS B SURFACE ANTIGEN; LIOTHYRONINE; MONOCLONAL ANTIBODY; PEPTIDE; PROLACTIN; RHEUMATOID FACTOR; THYROTROPIN; TROPONIN I;

ANALYTICAL EQUIPMENT; CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; ECTOPIC PREGNANCY; GENERAL SURGERY; GOOD LABORATORY PRACTICE; HEART INFARCTION; HUMAN; IMMUNOASSAY; LABORATORY; LABORATORY TEST; MEDICAL EDUCATION; NONHUMAN; PATIENT CARE; PHYSICIAN; REVIEW; SAFETY; SENSITIVITY AND SPECIFICITY;

EID: 0037025707     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04703.x     Document Type: Review

References (10)

1. Cancer misdiagnosed
2. Use of hCG tests for evaluating trophoblastic diseases: Choosing an appropriate hCG assay, false detection of hCG, unexplained elevated hCG, and quiescent trophoblastic disease. USA hCG Reference Service Report
3. Incidence and specificity of interference in two-site immunoassays
4. Heterophilic antibody interference with cardiac T quantitative rapid assay
5. False increase of cardiac troponin I with heterophilic antibodies
6. High percentage of false positive cardiac troponin I results in patients with rheumatoid factor
7. Interference in immunoassay
8. Wrong biochemistry results
9. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases
10. Standards of medical care for patients with diabetes mellitus